The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis

Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD)

(2011) P. Manghat et al.   BONE

Management of Osteoporosis in CKD Stages 3 to 5

(2010) Patricia L. Gordon et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

The osteocalcin propeptide is not secreted in vivo or in vitro

(2010) Caren M. Gundberg et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The renal clearance of free and conjugated pyridinium cross-links of collagen

(2010) A. Colwell et al.   JOURNAL OF BONE AND MINERAL RESEARCH

2009 Japanese Society for Dialysis Therapy Guidelines for Peritoneal Dialysis

(2010)   THERAPEUTIC APHERESIS AND DIALYSIS

Using biochemical markers of bone turnover in clinical practice

(2009) F. R. SINGER et al.   CLEVELAND CLINIC JOURNAL OF MEDICINE

Parathyroid hormone measurement in CKD

(2009) Jean-Claude P. Souberbielle et al.   KIDNEY INTERNATIONAL

Serum Levels of TRAP5b, a New Bone Resorption Marker Unaffected by Renal Dysfunction, as a Useful Marker of Cortical Bone Loss in Hemodialysis Patients

(2008) Kaori Shidara et al.   CALCIFIED TISSUE INTERNATIONAL

Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction

(2008) Shinsuke Yamada et al.   CLINICAL ENDOCRINOLOGY

Reference intervals of serum tartrate-resistant acid phosphatase type 5b activity measured with a novel assay in Japanese subjects

(2008) Yoshiki Nishizawa et al.   JOURNAL OF BONE AND MINERAL METABOLISM

K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients

(2008) F.C. Barreto et al.   KIDNEY INTERNATIONAL